Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-24-040517)

Filing Details

Accession Number:: 0001104659-24-040517
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-28 16:08:37
Reporting Period:: 2024-03-26

Accepted Time:: 2024-03-28 16:08:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1400118	Sagimet Biosciences Inc.	SGMT	Pharmaceutical Preparations (2834)	205991472

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1623567	David Happel	Sagimet Biosciences Inc. 155 Bovet Rd., Suite 303 San Mateo CA 94402	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Series A Common Stock	Acquisiton	2024-03-26	12,100	$5.27	639,200	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.24 per share to $5.2999 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.